Live Quote · NYSEPENHealthcare· Medical - Devices

Penumbra, Inc.

$318.57 0.68%(+$2.14)
TickerSpark Score
79/100
Solid
50
Valuation
90
Profitability
95
Growth
100
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PEN research report →

52-Week Range69% of range
Low
$221.26
Current
$318.57
High
$362.41
Company Overviewwww.penumbrainc.com

About the company

Penumbra, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

CEO
Adam Elsesser
IPO
2015
Employees
4,600
HQ
Alameda, CA, US

Price Chart

+27.56% · this period
$359.40$292.47$225.54Jul 02Dec 31Jul 02
Valuation
Market Cap
$12.53B
P/E
72.73
P/S
8.62
P/B
8.49
EV/EBITDA
56.59
Div Yield
0.00%
Profitability
Gross Margin
67.38%
Op Margin
12.87%
Net Margin
11.76%
ROE
12.32%
ROIC
9.26%
Growth & Income
Revenue
$1.40B · 17.50%
Net Income
$177.69M · 1168.11%
EPS
$4.57 · 1169.44%
Op Income
$189.25M
FCF YoY
18.76%
Performance & Tape
52W High
$362.41
52W Low
$221.26
50D MA
$321.93
200D MA
$309.28
Beta
0.70
Avg Volume
450.86K

Get TickerSpark's AI analysis on PEN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 19, 26Elsesser Adamother77,000
Apr 2, 26Grewal Harpreetsell100
Mar 15, 26Narayan Shruthiother117
Mar 15, 26Roberts Johannaother186
Mar 15, 26Yuen Maggieother186
Mar 15, 26Shiu Lambertother150
Mar 2, 26Yuen Maggiesell2,432
Feb 13, 26Grewal Harpreetother589
Feb 13, 26Bose Araniother589
Feb 13, 26Leeds Janetother589
Coverage · PEN

Our PEN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PEN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PEN report →
Internal Compare

Similar companies

Peers in the same neighborhood.